王 旭,陈 虹,范铁艳.肝移植术后新发恶性肿瘤的临床分析[J].中国肿瘤,2017,26(5):410-414. |
肝移植术后新发恶性肿瘤的临床分析 |
Clinical Analysis on De Novo Malignancies After Liver Transplantation |
投稿时间:2016-07-26 |
DOI:10.11735/j.issn.1004-0242.2017.05.A017 |
|
 |
中文关键词: 新发恶性肿瘤 肝移植 免疫抑制剂 |
英文关键词:de novo malignancies liver transplantation immunosuppressant |
基金项目: |
|
摘要点击次数: 2008 |
全文下载次数: 729 |
中文摘要: |
摘 要:[目的] 探讨及总结肝移植术后新发恶性肿瘤的发病原因、临床特点及诊疗方案,从而为其预防、早期诊断及治疗提供指导和帮助。[方法] 随访2042例行肝移植手术的患者,回顾性分析肝移植术后新发恶性肿瘤的发病情况、患者的诊治经过及预后。[结果] 共确诊肝移植术后新发恶性肿瘤16人(17例次),肝移植术后新发恶性肿瘤的发生率为0.840%。[结论] 随着移植受者存活时间的延长,移植术后新发肿瘤的发生应引起关注。 |
英文摘要: |
Abstract:[Purpose] To investigate and summarize the pathogenesis,clinical characteristics,diagnosis and treatment schemes of de novo malignancies after liver transplantation,and to provide guidance and assistance for prevention,early diagnosis and treatment of it. [Methods]Two thousand and forty two cases of liver transplant recipients were followed up,and the incidence,diagnosis,treatment and prognosis of de novo malignant tumor after liver transplantation were analyzed retrospectively. [Results] De novo malignancies were found in 16 cases(17 case-times) of 2042 liver transplant recipients,the incidence of new malignancies after liver transplantation was 0.840%(17/2042). [Conclusion] With the extension of the survival time of transplant recipients,the occurrence of de novo malignant tumor after transplantation should be paid attention to. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|